Research Administrative Pre-Authorization (RAP) PROPOSAL TEMPLATE FORM RAP review is required for all research conducted at Aurora. You will receive an email describing the outcome of this review; a favorable pre-authorization is required before you can continue with the project approval, for example: submission to the IRB/IACUC, medical record release, etc. This form is not expected to be an in-depth, complete protocol. However, it is important that you provide enough details so that the reviewer can accurately assess the rationale, processes and outcomes in order to make the determination as to whether the proposal is meritorious and in alignment with the priorities and mission of Aurora Health Care and the Aurora Research Institute (ARI). Pages 3-4 of this form provide details and examples to reference when completing this form. Use the complete guide or the icons though out this form to link to the relevant section. This form should be completed by the Program Director/Principal Investigator (PD/PI)/ Research Regulatory Specialist Submit completed form to research.preauthorization@aurora.org If you need help in completing this proposal, please contact ARI staff research.preauthorization@aurora.org or 414-219-7886 CONTACT INFORMATION PD/PI name: Aurora Employee?(yes or no) Co-I name(s) (if applicable): Aurora Employee?(yes or no) Address/location: Department: Email: Phone: Regulatory Specialist name (if applicable): Email: Will any data leave Aurora? Yes Non-Aurora collaborators: Name: No Explain: Institution: Explain: IIR RAP proposal template v.2.3 3Nov2015 Page 1 of 5 GENERAL INFORMATION Date of submission: Category of research (highlight all that that apply) - Industry funded clinical trial - - Investigator Initiated human subject research - Cardiology Fellows (as study lead) * PI cannot submit RAP request directly. Send request to Sara.Walczak@aurora.org for pre-review - Animal research - Basic science research - other Use of a DRUG, DEVICE, or BIOLOGIC (FDA requirements/considerations) Does this proposal involve the use of a DRUG, DEVICE, or BIOLOGIC (other than those already approved for use in the indicated population) in research subjects? If yes, provide a brief explanation. Drug: Yes Device: Yes No No Biologic: Yes No Combination product: Yes No Brief Explanation: Are you a nurse? Yes No Are you a fellow, resident, or other student? Describe: IIR RAP proposal template v.2.3 3Nov2015 Page 2 of 5 STUDY DETAILS Study title Background and literature Study Rationale/Merit Hypothesis/aims/objectives Study design and methods Population/samples size Subject recruitment/informed consent Consideration of Risks and Benefits Data analysis and review Resource availability and timeline Outcomes Key References IIR RAP proposal template v.2.3 3Nov2015 Page 3 of 5 GUIDELINES For Completing Research Administrative Pre-Authorization (RAP) Proposal Form FDA considerations/ requirements back to form Include a description of the use of drugs, medical devices or biologics used in the research. It is important to address any FDA considerations or requirements if the study: - involves the use of a DRUG or a BIOLOGIC in a human other than the use of an approved drug in the course of medical practice. - evaluates the safety or effectiveness of a DEVICE in research subjects, a control group or their biological specimens. - involves a Humanitarian Use Device (“HUD”) in a research study. If you answered “Yes” to any of the questions above, please note that the IND/IDE committee will review the protocol prior to scientific review and an FDA application may be required. Study title back to form Make your title specific and detailed. If your application is a revision, do NOT change the title. Background and literature back to form Include the background and history for this topic. Study Rationale/Merit back to form State the problem and provide justification and rationale for the proposed research – rationale should be placed within the context of existing literature or within your own observation (medical need, clinical relevance, advantage of suggested approach over current best medical practice). Relate this to the longer-term, big picture scientific objectives and how this study will impact the subject, this patient population and/or society, including a description of the public health impact. Hypothesis/aims/objectives back to form Describe the overall objectives including primary and any secondary objectives (objectives should be specific and well defined). Outline the research question(s) and hypothesis(ses) to be tested by the study. Study design and methods back to form Describe the type of research, for example chart review (retrospective or prospective) or randomized, placebo controlled, phase I, II or III. Identify the sites involved, if applicable. Give an overview of all study-related procedures and treatments during study visits. Be sure to create a clear differentiation between research procedures and standard care. Outline the process for specimen/data collection. Things to consider for specimen/data banking studies: What types of specimens/data will be collected? Where will the specimens/data be housed and who will be responsible for oversight of the bank (including future use)? How long will specimens/data be kept? How are the specimens going to be used? How will the specimens/data be destroyed upon study completion? IIR RAP proposal template v.2.3 3Nov2015 Page 4 of 5 Things to consider for record review studies: What is the source of the medical information? Does the medical record information to be used in the study already exist? Who will have access to this collected information? Are there any plans for coding or de-identifying the information that is collected? How long will the information be kept and what are the plans for destroying it once the study is completed? Create a list of variables that will be abstracted from the medical record ("data collection tool"). Population/samples size back to form Describe the study population, including subject characteristics and general inclusion/exclusion criteria. Provide details of sample size. Subject recruitment/informed consent back to form Provide some a general idea about the methods proposed for screening and enrolling subjects. Outline procedures for obtaining informed consent (if not waived). Consideration of Risks and Benefits back to form Summarize any anticipated risks including safety, financial or conflict of interest. Address whether or not the study is of benefit the subjects as well to Aurora, Aurora patients and the community. Please note that if your submission requires IRB review, the IRB will require a detailed discussion of risks and benefits. Depending on the study, they may also require a data and safety monitoring plan. Data analysis and review back to form Describe how the data will be used to answer your research question. Provide an overview of the statistical analyses will you use and how will you interpret the results. If you need help from biostatisticians, please contact the IIR Research Regulatory Specialist at 414-2197886 or research.preauthorization@aurora.org Resource availability and timeline back to form Address your timeframe, including expected start date and completion date and whether this study can be done effectively within that time (including data analysis and abstract/manuscript preparation). Indicate if you have the necessary equipment, space, support staff and other facilities to conduct the research. If you need additional resources for the completion of this project, please provide details. Provide details of funding source if available. If you have existing funding for your study, please submit the related budget and budget justification. If you need assistance with identification of funding source or a grant application, please contact the Sponsored Programs Office at 414-219-7803 or SPO@aurora.org Outcomes back to form Identify the overall anticipated outcome. Describe how successful completion of the proposal produce a patient-centered outcome in one or multiple dimensions (individual patient, social, system, specific application and the medical/healthcare field) Identify where you plan to present the results (national meeting, publication, etc.) IIR RAP proposal template v.2.3 3Nov2015 Page 5 of 5